Skip to Main Content


  • sam patrick posted an article
    Top speakers and brands are committing to attend SCBIO 2017 in Charleston this October; have you sig see more

    BIO global CEO Jim Greenwood will join South Carolina Governor Henry McMaster as featured luncheon speakers on the first full day of SCBIO 2017 – the annual conference bringing top leaders and executives from organizations across the life sciences industry to Charleston, South Carolina October 24–26.

    Mr. Greenwood will be addressing the gathering with a keynote presentation entitled “Global Trends for the Life Sciences Industry – and Implications for South Carolina” at lunch on October 25.  South Carolina Governor Henry McMaster will follow with a presentation entitled “Life Sciences Powered by Public/Private Partnership – A Strategic View from the Statehouse.”

    Dozens of top industry chief executives, leaders in government and higher education, biotechnology and pharma executives, and industry supporters from across America have already committed to attend SCBIO 2017 at Charleston’s Gaillard Auditorium, organizers confirmed today.  Among the committed speakers and panelists are Nephron Pharmaceuticals CEO Lou Kennedy, MUSC President David Cole, Clemson University President Jim Clements, USC President Harris Pastides, Medpoint CEO Chuck Crumpton, Belimed CEO Joseph McDonald, AVX Health Division executive Robert Fairey and numerous others.

    Themed “Building the Business of Life SCiences in SC”, the 2+ day conference draws attendees from across America for networking, innovation updates, opportunity discovery, partnership making and strategic discussion.  Committed attendees include officials across a broad spectrum of life sciences industries including medical devices, bio manufacturing, drug discovery, pharmaceuticals, diagnostics and testing, digital health and health IT, bio ag  and more.  While space is limited and advance registration is required, interested attendees can still register at

    SCBIO is South Carolina’s investor-driven economic development organization exclusively focused on building, advancing, and growing the life sciences industry in the state.  The industry has an $11.4 billion economic impact in the Palmetto State, with more than 400 firms directly involved and 15,000 professionals employed in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotechnology products. 

    SCBIO 2017 kicks off Tuesday evening with a Welcome Reception for conference registrants, speakers and sponsors on the rooftop terrace of the Grand Bohemian Hotel.  Wednesday will feature a full day of sessions beginning at breakfast with a greeting by Charleston Mayor John Tecklenburg and continuing through an evening reception.  The conference will wrap up Thursday at lunchtime. 

    “The life sciences industry has become a major driver of South Carolina’s economy,” noted South Carolina Secretary of Commerce Bobby Hitt recently. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, we know that this sector has tremendous growth potential, and we’re excited to be partnering with SCBIO to help life sciences continue to advance in South Carolina.”  SC Commerce is a Founding Partner of SCBIO and of the Conference.

    Among the leading biotech industry brands participating in the conference are Nephron Pharmaceutical, BIO, Johnson & Johnson, AVX, PhRMA, Medpoint, AdvaMed, Poly-Med, VWR, Ritedose Corporation, Rhythmlink, Softbox, NCGS and SEMDA.  All of South Carolina’s research universities – MUSC, Clemson and the University of South Carolina – are attending, as is Greenville Health System and economic development entities including SCRA, the Upstate SC Alliance, the Charleston Regional Development Alliance and SiMT.

    As the official state affiliate of BIO -- the world's largest trade association representing biotechnology organizations – SCBIO members include hundreds of academic institutions, biotech companies, entrepreneurial organizations, service providers, thought leaders, economic development organizations and related groups whose members are leading the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products that transform how we heal, fuel and feed the world.

    For additional information on SCBIO, visit  To register for SCBIO 2017, visit

     September 27, 2017
  • Ty Kourlas posted an article
    South Carolina Department of Commerce supporting public-private partnership to advance life sciences see more

    COLUMBIA, S.C. – South Carolina’s life sciences industry has an annual economic impact of approximately $11.4 billion, according to a study commissioned by the S.C. Research Authority (SCRA) and S.C. Biotechnology Industry Organization (SCBIO) in partnership with the S.C. Department of Commerce (S.C. Commerce). Prepared by the University of South Carolina’s Darla Moore School of Business, the study finds that this growing sector has experienced an average annual employment growth rate of approximately 1.7 percent in the Palmetto State since 2005.

    With a footprint of more than 15,000 employees and 400 firms in South Carolina, life sciences has developed into a critical component of the state’s economy and, as such, presents significant opportunities for economic growth. According to the study, the life sciences industry is associated with an employment multiplier of 2.9; meaning that, for every 10 jobs created within the industry, an additional 19 jobs are created elsewhere in the state.

    Typically, these jobs are high-paying. The average direct job in South Carolina’s life sciences industry pays an annual total compensation of $78,658, which is approximately 95 percent higher than the state’s average annual compensation across all jobs.

    “The life sciences industry has become a major driver of South Carolina’s economy,” said Secretary of Commerce Bobby Hitt. “Already accounting for thousands of highly-skilled jobs in the Palmetto State, we know that this sector has tremendous growth potential, and we’re excited to be partnering with SCBIO to help life sciences continue to advance in South Carolina.”

    In July 2016, S.C. Commerce formed a partnership with SCBIO to determine the footprint of this sector in South Carolina. The first step in the partnership was to complete an economic impact study. Now that the study has been concluded and the scope of the state’s life sciences industry has been identified, the two organizations have forged a memorandum of understanding (MOU) that outlines shared goals and objectives designed to further catalyze and grow the life sciences industry in South Carolina.

    A similar framework has been successfully implemented by S.C. Commerce with other industry sectors in recent years, including with the aerospace and logistics sectors. This MOU includes the creation of an unprecedented strategic plan for accelerating the development of the state’s burgeoning life sciences industry sector, and it’s expected to produce measurable results in the years ahead.   

    “The data generated by this economic study confirms the positive and significant impact that the life sciences industry is already having on the economy of South Carolina,” said SCBIO President and Chief Executive Officer Sam Konduros. “This data creates a solid foundation for future efforts and builds a clear and compelling case for why S.C. Commerce and SCBIO are deepening our partnership, implementing new joint strategies and synchronizing our collective efforts to further diversify and expand the economy of South Carolina through the power of the life sciences industry.”

    For more on the study, view this fact sheet or access the full report by clicking here